Variables | All n = 60 |
Antihypertensive drug duration, months | 13.0 (8.7 - 17.4) |
Antihypertensive drug classes, n (%) |
|
CCB | 60 (100) |
Thiazides | 59 (98.3) |
Mineralocorticoid antagonists | 13 (21.7) |
ACEIs | 32 (53.3) |
ARBs | 27 (45.0) |
Beta-blockers | 17 (28.3) |
Antihypertensivedrugregimen, n (%) |
|
3 drugs | 32 (53.3) |
4 drugs | 26 (43.3) |
5 drugs | 2 (3.3) |